Skip to main content

Table 2 Patient and tumour characteristics for proteomics validation

From: Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer

 

TFC (n = 12)

PCa (n = 17)

CRPC (n = 15)

Age (years)

   

 Median (range)

66.5 (46–77)

70.5 (53–83)

71 (55–83)

Baseline PSA (ng/mL)

   

 Median (range)

 

10.08 (0.13–149)

120 (5.9–137.9)

Local treatment, n (%)

   

 Radical prostatectomy

 

15 (88.2%)

 

 Endocrinotherapy

  

8 (53.33%)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us